Expertise in
3
conditions

Dr. John M. Pullman

Infectious Disease | Intensive Care Medicine
Cogent Healthcare Of Montana P C
1101 26th St S, 
Great Falls, MT 
Accepting New Patients
Expertise in
3
conditions
Cogent Healthcare Of Montana P C
1101 26th St S, 
Great Falls, MT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Pullman is an Infectious Disease specialist and an Intensive Care Medicine provider in Great Falls, Montana. Dr. Pullman is highly rated in 3 conditions, according to our data. His top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Osteomyelitis, and Osteomyelitis in Children. Dr. Pullman is currently accepting new patients.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Infectious Disease
Intensive Care Medicine
Licenses
Internal Medicine in MT
Hospital Affiliations
Community Hospital Of Anaconda
St James Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

COGENT HEALTHCARE OF MONTANA P C
1101 26th St S, Great Falls, MT 59405
Other Locations
MERCURY STREET MEDICAL GROUP PLLC
300 W Mercury St, Butte, MT 59701
COGENT HEALTHCARE OF MONTANA P C
400 S Clark St, Butte, MT 59701

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
Enrollment Status: Completed
Publish Date: June 13, 2025
Intervention Type: Drug
Study Drug: CRS3123
Study Phase: Phase 2
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3
Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm, 12-week Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm, 12-week Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
Enrollment Status: Suspended
Publish Date: February 08, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy of SER-262 in Adults With Primary Clostridium Difficile Infection (CDI) to Prevent Recurrence
A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy of SER-262 in Adults With Primary Clostridium Difficile Infection (CDI) to Prevent Recurrence
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 3, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Cefepime-AAI101 Compared to Piperacillin/Tazobactam in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis.
A Phase 3, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Cefepime-AAI101 Compared to Piperacillin/Tazobactam in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis.
Enrollment Status: Completed
Publish Date: March 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

18 Total Publications

Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials.
Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials.
Journal: Critical care (London, England)
Published: July 24, 2024
Similar Doctors
Expertise in
10
conditions
Dr. Holly C. Strong
Intensive Care Medicine | Pulmonary Medicine
Expertise in
10
conditions
Dr. Holly C. Strong
Intensive Care Medicine | Pulmonary Medicine

Benefis Hospitals Inc

1101 26th St S, 
Great Falls, MT 
 (0.1 miles away)
406-455-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Holly Strong is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Great Falls, Montana. Dr. Strong is highly rated in 10 conditions, according to our data. Her top areas of expertise are Lung Metastases, Pleurisy, Pleural Effusion, Endoscopy, and Thymectomy. Dr. Strong is currently accepting new patients.

Expertise in
7
conditions
Dr. Robert M. Grasseschi
Pulmonary Medicine | Intensive Care Medicine
Expertise in
7
conditions
Dr. Robert M. Grasseschi
Pulmonary Medicine | Intensive Care Medicine

Benefis Hospitals Inc

1101 26th St S, 
Great Falls, MT 
 (0.1 miles away)
406-455-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Grasseschi is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Great Falls, Montana. Dr. Grasseschi is highly rated in 7 conditions, according to our data. His top areas of expertise are Lung Metastases, Pulmonary Veno-Occlusive Disease, Bronchogenic Cyst, Gastrostomy, and Endoscopy. Dr. Grasseschi is currently accepting new patients.

Expertise in
2
conditions
Dr. Elias J. Baied
Infectious Disease | Hospital Medicine
Expertise in
2
conditions
Dr. Elias J. Baied
Infectious Disease | Hospital Medicine

Benefis Hospitals Inc

1401 25th St S, 
Great Falls, MT 
 (0.1 miles away)
406-455-5000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Elias Baied is an Infectious Disease specialist and a Hospital Medicine provider in Great Falls, Montana. Dr. Baied is highly rated in 2 conditions, according to our data. His top areas of expertise are Infectious Arthritis, Strep Throat, Osteomyelitis, and Osteomyelitis in Children. Dr. Baied is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pullman's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile